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Hop Is an Unusual Homeobox Gene
that Modulates Cardiac Development
tion and are arranged in the genome in the order in
which they are expressed along the axis of the embryo.
The “Hox code” represents an important paradigm for
Fabian Chen,1 Hyun Kook,1 Rita Milewski,1
Aaron D. Gitler,1,2 Min Min Lu,1 Jun Li,1
Ronniel Nazarian,1 Robert Schnepp,1
the definition of positional identity during embryogene-Kuangyu Jen,1 Christine Biben,3 Greg Runke,2
sis in which the specific pattern of overlapping Hox geneJoel P. Mackay,5 Jiri Novotny,3
expression defines cellular identity. A plethora of non-Robert J. Schwartz,6 Richard P. Harvey,3,4
clustered Hox genes have been identified that are scat-Mary C. Mullins,2 and Jonathan A. Epstein1,2,7
tered throughout the genome and play additional roles1Department of Medicine
in cell fate specification in all organs and tissues of the2 Department of Cell and Developmental Biology
body.University of Pennsylvania Health System
Hox genes are defined by the presence of a 60 aminoPhiladelphia, Pennsylvania 19104
acid domain that mediates DNA binding. This domain3 The Victor Chang Cardiac Research Institute
has been analyzed by NMR spectroscopy and X-rayDarlinghurst, NSW 2010
crystallography either free or in association with DNAAustralia
(Kissinger et al., 1990; Qian et al., 1989; Wolberger et4 Faculties of Medicine and Life Sciences
al., 1991). The 60 amino acid homeodomain is capableUniversity of New South Wales
of adopting a fixed structure in solution composed ofKensington, NSW 2051
three  helices in which the second and third helicesAustralia
form a helix-turn-helix motif. The third helix sits in the5 School of Molecular and Microbial Biosciences
major groove of DNA and makes critical DNA contacts.University of Sydney
Within this third  helix, several amino acids that makeNSW 2006
direct contact with DNA are conserved amongst allAustralia
known homeodomains. Other residues vary only slightly6 Department of Cell Biology
and define subclasses of Hox genes. For instance, ho-Baylor College of Medicine
meodomains of the goosecoid class contain a lysine atHouston, Texas 77030
position 9 of the third helix, while those of the paired
class contain a serine at this position (Duboule, 1994).
Hox proteins are thought to act by modulating tran-Summary
scription, and all known Hox gene products contain do-
mains in addition to the homeodomain that are capableHop is a small, divergent homeodomain protein that
of activating or repressing transcription, mediating pro-lacks certain conserved residues required for DNA
tein-protein interactions or binding to DNA. For instance,binding. Hop gene expression initiates early in cardio-
in the developing heart, Nkx2-5 encodes a homeodo-genesis and continues in cardiomyocytes throughout
main protein that includes amino-terminal and carboxy-embryonic and postnatal development. Genetic and
terminal transcriptional activation domains in additionbiochemical data indicate that Hop functions directly
to the homeodomain (Chen and Schwartz, 1995; Komurodownstream of Nkx2-5. Inactivation of Hop in mice
and Izumo, 1993; Lyons et al., 1995; Ranganayakulu etby homologous recombination results in a partially
al., 1998). Nkx2-5 is homologous to the Drosophila genepenetrant embryonic lethal phenotype with severe de-
tinman that is required for heart formation in the flyvelopmental cardiac defects involving the myocar-
(Komuro and Izumo, 1993). In vertebrates, multiple re-dium. Inhibition of Hop activity in zebrafish embryos
lated Nkx2 homeobox genes are expressed in the heart
likewise disrupts cardiac development and results in
and probably serve redundant functions (Harvey, 1996).
severely impaired cardiac function. Hop physically in- In Xenopus embryos, injection of dominant-negative
teracts with serum response factor (SRF) and inhibits forms of Nkx2-5/Nkx2-3 prevent cardiac development
activation of SRF-dependent transcription by inhib- (Fu et al., 1998).
iting SRF binding to DNA. Hop encodes an unusual Nkx2-5 acts synergistically with other transcription
homeodomain protein that modulates SRF-dependent factors expressed in the developing heart to activate
cardiac-specific gene expression and cardiac devel- expression of cardiac-specific genes. In particular,
opment. Nkx2-5, Gata4, and serum response factor (SRF) func-
tion together by binding to adjacent sites within the
Introduction promoter/enhancer region of cardiac genes (Chen et al.,
1996; Chen and Schwartz, 1996; Durocher et al., 1997).
One of the landmark discoveries in developmental biol- This particular constellation of binding sites is found
ogy was the identification of clustered homeobox or in the upstream genomic regions of some, but not all,
Hox genes that encode transcription factors required developmentally regulated cardiac genes. Recently, a
for patterning the embryo along the anterior-posterior cardiac-specific transcription cofactor named myocar-
axis (reviewed in Duboule, 1994). These clustered Hox din was identified that contains a homeobox-like subdo-
genes are conserved across millions of years of evolu- main and binds to SRF, effecting potent transcriptional
activation (Wang et al., 2001). Hence, multiple cardiac-
specific gene regulatory networks converge on SRF to7 Correspondence: epsteinj@mail.med.upenn.edu
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Figure 1. Sequence and Expression of Anal-
ysis of Hop
(A) Mouse and human amino acid sequence
for Hop. A comparison is made with Xenopus
Goosecoid, human PAX6, and a consensus
homeodomain sequence (Duboule, 1994).
Conserved amino acid residues are shown
in red. Amino acid residues conserved in all
homeodomain are shown in blue. Hop has a
lysine at amino acid position 52 (*), which is
typical of the Goosecoid protein. Hop also
has a glutamine at position 53 (†) and a leu-
cine at 55 (†), which differ from the highly
conserved asparagine and arginine, respec-
tively found in all other homeodomains.
(B) Whole-mount in situ at E9.5 revealing ex-
pression in the branchial arches (ba) and
heart (ht). (Signal in the hindbrain is artifactual
due to probe trapping.)
(C) Whole-mount in situ reveals expression
of Hop in the heart at E10.5 (left) and in the
heart and neural tube (nt) at E12.5 (right). The
heads have been removed to improve visual-
ization of the heart.
(D) Posterior view at E12.5 indicating expres-
sion in the neural tube.
(E) Radioactive in situ hybridization of trans-
verse section at E12.5 reveals strong Hop expression in all four cardiac chambers (ht) and in the ventricular zone of the neural tube (nt).
(F) Northern blot of mouse Hop demonstrating a 1.2 kb mRNA transcript present in E12.5 heart and not in the embryo with the heart removed.
Adult mouse heart, brain, intestine, and spleen express Hop mRNA.
mediate cardiac gene transcription during development ing frame with a 60 amino acid motif homologous to
Hox gene products. At the amino acid sequence level,and disease.
In this report, we describe and characterize an un- Hop is most closely related to homeodomain proteins
Pax6 and goosecoid, with 40% identity and 57%usual type of homeodomain protein that functions dur-
ing cardiac development called Hop (homeodomain only similarity evident within the homeodomain-like domain
(Figure 1A). Optimal alignment strategies suggest thatprotein, previously referred to as Toto and identified
independently by others as Cameo; Shin et al., 2002 [this Hop has a single amino acid insertion near the end
of the predicted first  helix when compared to otherissue of Cell]). Hop is coexpressed with and functions
downstream of the mammalian tinman homolog Nkx2-5. homeodomain proteins. To model the Hop protein
against other known protein structures, we subjectedHop is the smallest known homeodomain protein. It is
composed of a divergent homeodomain that is incapa- the 73 amino acid Hop sequence to protein threading
ble of sequence-specific DNA binding. Instead, Hop calculations using the ProCeryon algorithm (Sippl and
functions by interacting with SRF to inhibit DNA binding. Weitckus, 1992; Jones et al., 1992). Results indicated
This interaction results in decreased transcription of that some 6 homeodomain structures from species as
SRF-dependent cardiac-restricted genes. Genetic inac- diverse as fruitfly and man scored higher than any other
tivation of Hop in mice results in a partially penetrant protein in the PDB, making it highly probable that Hop
phenotype of embryonic heart failure and lethality, while belongs to the homeodomain superfamily. The highest
morpholino antisense oligonucleotide inactivation of scoring homeodomain folds were those of Drosophila
Hop in zebrafish results in impaired cardiac contractility paired and engrailed, and human PBX1 and HOX-B1,
and function. Our results identify an atypical homeodo- showing 19%–28% residues both aligned in sequence
main protein and describe an unusual function for this and structurally superimposed. Least squares (best fit)
conserved structural motif in heart development. superimpositions showed these 4 homeodomains to be
highly similar in their detailed structures (average root-
mean-square error of 1.4 A˚). This group of homeodo-Results
mains therefore provides an excellent structural tem-
plate for the Hop fold.We identified mouse Hop in an expressed sequence tag
Like goosecoid, Hop has a Lys at position 52 (see(EST) database search for transcripts encoding proteins
numbering in Figure 1A; this position in Hop corre-related to paired-type homeodomains expressed in the
sponds to position 50 of the goosecoid homeodomain).heart. Further analysis of EST databases revealed a hu-
This amino acid has been identified as an importantman homolog of Hop (designated HOP), encoding a
contributor to DNA binding specificity of most homeo-protein with 92% identity to the mouse sequence (Figure
domains (Treisman et al., 1989). Furthermore, Hop con-1A). Homologs were also present in rat, cow, pig, chick,
tains a Trp at position 50 and Phe at position 51, residuesXenopus, and zebrafish, but we failed to identify C. ele-
that are conserved amongst all known homeodomains.gans or Drosophila Hop genes.
The Hop protein contains a 73 amino acid open read- While these conservations and results from the thread-
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ing calculations suggest that Hop is highly likely to adopt transgenic embryos (Figure 3B). Interestingly, left ven-
tricular expression was not seen, suggesting that Hopa homeodomain-like fold, comparison of the protein se-
quence with sequences from other homeodomains sug- transcription is regulated by distinct modular enhancers
directing chamber-specific expression, as has beengests that Hop is unlikely to have retained DNA binding
function. First, the amino acids at positions 53 and 55 demonstrated extensively for other cardiac-specific
genes including Nkx2-5 (Schwartz and Olson, 1999). We(Gln and Leu, respectively) diverge from the highly con-
served Asn and Arg that are found in all other homeodo- constructed a human growth hormone reporter con-
struct using this 5 kb Hop genomic sequence and testedmains and which make important binding contact in the
major groove of DNA (Duboule, 1994). Second, a number the ability of Nkx2-5 to activate reporter gene expression
in transient transfection assays using NIH3T3 cells. Co-of residues that commonly make ion-pair interactions
with DNA in homeodomains are absent in Hop (Billeter transfection of Nkx2-5 resulted in a roughly dose depen-
dent increase in reporter activity (Figure 3C), consistentet al., 1993 and Wolberger et al., 1991). Third, Tyr27 and
Ile49 take part in extensive hydrophobic interactions with the hypothesis that Nkx2-5 directly regulates Hop
expression. The 5 kb Hop genomic sequence containswith nucleotide bases, and neither of these amino acids
is conserved in Hop. While not all homeodomains exhibit 12 potential high affinity Nkx2-5 binding sites conform-
ing to the consensus TNNAGTG (Chen and Schwartz,all of these interactions, the fact that Hop is missing
many of them provides strong support for the hypothesis 1995). We examined the ability of Nkx2-5 to bind to the
most proximal putative binding site using EMSA. Nkx2-5that Hop has lost its DNA binding function. Thus, we
consider Hop to be an atypical member of the homeodo- was able to bind to this site in a sequence-specific
fashion and mutation of the core sequence eliminatedmain superfamily.
binding (Figure 3D). We next constructed a reporter plas-
mid that contained only the proximal 261 bp of HopHop Expression in the Embryo and Adult
genomic sequence from the 5 kb Hop genomic promoterWhole-mount in situ hybridization indicates that Hop is
used above that includes a single Nkx2-5 binding site.strongly expressed throughout the myocardium at E9.5
Nkx2-5 was able to induce reporter gene activationand in the branchial arches (Figure 1B). At E12.5, Hop
when cotransfected in NIH3T3 cells, and introduction ofexpression is evident in the heart and in the ventricular
the identical missense mutation that abolished Nkx2-5zone of the neural tube (Figures 1C–1E). At E13.5, low
binding in the EMSA greatly reduced the ability of Nkx2-5level expression is also seen in the intestinal epithelium,
to induce transactivation (Figure 3E). These resultsand by E16.5, expression is seen in the airway epithelium
strongly support the hypothesis that Nkx2-5 is a directof the lung (not shown). Northern analysis of adult and
regulator of Hop gene expression.embryonic tissues indicates that Hop is encoded by a
1.2 kb mRNA transcript present in the embryonic and
adult heart and in the adult brain, intestine, and spleen Hop Encodes a Nuclear Protein
(Figure 1F). Throughout embryonic and postnatal devel- that Does Not Bind DNA
opment, Hop is expressed in the myocardium. Most homeodomain-containing proteins are nuclear
transcription factors that bind to short specific DNA
sequences containing ATTA or related motifs (TreismanHop Functions Downstream of Nkx2-5
In situ hybridization analysis reveals that Hop is not et al., 1989). We confirmed that Hop encodes a nuclear
protein by transfecting NIH-3T3 cells with an epitope-expressed at E7.5 in the lateral plate mesoderm (arrows,
Figure 2A) when cardiogenic precursors are specified, tagged version of Hop and performing immunohisto-
chemistry (data not shown). We performed electropho-as evidenced by expression of Nkx2-5 (arrows, Figure
2B). Shortly thereafter (E8.0), Hop is expressed in the retic mobility shift assays (EMSA) to determine if Hop
was able to bind to previously identified consensusbilateral clusters of precardiac mesoderm (Figure 2C)
and expression persists in the myocardium. Of note, the binding sites for members of the bicoid/goosecoid, NK,
even skipped, or paired families of homeodomain pro-expression of Nkx2-5 in lateral plate mesoderm (Figure
2D) is slightly broader than that of Hop and includes the teins. While the isolated Pax3 homeodomain bound to
all of these sequences (with varying affinities), Hop didmaturing ventral foregut endoderm (compare Figures
2E and 2F). not bind to any of them, even under nonstringent condi-
tions (data not shown). Since Hop contains divergentSince Hop expression overlaps that of Nkx2-5 and
initiates just after that of Nkx2-5 during cardiac develop- amino acid residues at positions 53 and 55 not found
in other related proteins, we replaced these residuesment, we examined the expression of Hop in Nkx2-5 null
embryos. Hop mRNA transcripts were downregulated, with an Asn at position 53 and an Arg at position 55, thus
conforming to the homeodomain consensus sequence.although not eliminated, in Nkx2-5 null hearts at E9.5
(Figure 3A). These results indicate that Nkx2-5 acts to The modified Hop proteins were expressed efficiently
in bacteria, but these alterations were insufficient toinduce or maintain expression of Hop during cardiac
development. confer upon Hop the ability to bind consensus homeo-
domain sequences, presumably because of other diver-We examined the possibility that transcription of the
Hop gene might be activated by Nkx2-5. We identified gent residues (see above and Figure 1A).
To confirm that Hop does not bind directly to DNA,a genomic region upstream of Hop that was capable
of mediating cardiac-specific expression in vivo using we performed an unbiased binding site selection assay
(Epstein et al., 1994) with Hop, using the Pax6 homeodo-transgenic mice. Five kb of upstream sequence was
sufficient to direct expression of a lacZ reporter gene main in parallel as a control. After five rounds of selection
with pooled randomers containing a central core of 12in the right ventricle of three independent E10.5 transient
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Figure 2. Hop Expression Overlaps with that
of Nkx2-5
Radioactive in situ hybridization of mouse
embryos in their decidua from E7.5 (A and B),
E8.0 (C and D) and E8.5 (E and F). (A and B),
(C and D), and (E and F) are from adjacent
sections.
(A) Hop expression is not detected in precar-
diac mesoderm at E7.5 (arrows).
(B) Nkx2-5 is expressed at E7.5 in this tissue
(arrows).
(C) At E8.0, Hop is expressed in the forming
bilateral heart tubes and is restricted to the
cardiogenic region (arrows).
(D) Nkx2-5 is expressed in a similar pattern,
though expression extends ventrally beyond
that of Hop.
(E) At E8.5, Hop expression is restricted to
the heart (ht).
(F) Nkx-2.5 is coexpressed with Hop in the
heart. Nkx2-5 is also expressed in foregut en-
doderm (fg).
random nucleotides, the Pax6 homeodomain selected quences were selected with Hop. The results were simi-
lar to that seen with GST alone. Thus, we concludesequences containing a palindromic ATTA motif, as pre-
viously described (Wilson et al., 1993). No specific se- that Hop does not possess DNA binding ability under
Figure 3. Hop Functions Downstream of
Nkx2-5
(A) Whole-mount in situ hybridization indi-
cates Hop expression at E9.5 in wild-type
(left) and Nkx2-5 null (right) littermates. Hop
expression is significantly downregulated in
the heart (ht) and branchial arches in Nkx2-5
deficient embryos.
(B) 5 kb of the Hop promoter driving lacZ
expression results in right ventricular (rv) ex-
pression of -galactosidase activity at E10.5
in transgenic embryos. No expression is seen
in the left ventricle (lv).
(C) Transient transfection assays demon-
strate that a human growth hormone reporter
gene driven by the 5 kb mouse Hop promoter
is activated by cotransfection of Nkx2-5 in a
roughly dose-dependent manner. Results are
normalized for transfection efficiency in NIH-
3T3 cells.
(D) (left) EMSA revealing that Nkx2-5 can bind
to a Nkx2.5 binding site (NKE-WT) present in
the proximal Hop promoter, while it can not
bind a mutant Nkx2.5 binding site (mut). (right)
Binding of Nkx2.5 protein to the NKE is com-
peted by unlabeled wild-type but not the mu-
tant competitor oligonucleotide.
(E) Transient transfection assays demon-
strate that a human growth hormone reporter gene driven by the 261 bp proximal mouse Hop promoter is activated by cotransfection of
Nkx2-5, while activation is significantly reduced by mutation of the NKE.
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Figure 4. Inactivation of the Hop Gene
(A) Structure of the wild-type murine Hop locus, targeting vector, targeted locus, and targeted locus with the neomycin-resistance gene
removed. K, KpnI.
(B) Southern blot of KpnI digested genomic DNA hybridized with the 3 external probe.
(C) Top: Northern blot of total RNA from hearts isolated from newborn mice hybridized with a Hop cDNA probe. Bottom: Ethidium bromide
stained agarose gel.
(D) Western blot with rabbit polyclonal antiserum raised against bacterial Hop recognizes an 8 kDa band from bacterial extracts expressing
Hop (lane 1) and from E11.5 mouse hearts (lane 2). No Hop protein is detected in extracts from hearts of Hop/ embryos (lane 3). An -SRF
antibody was used to demonstrate approximate equal loading of protein in lanes 2 and 3 (bottom).
(E) Partial embryonic lethality of homozygous Hop embryos occurs between E10.5 and E12.5. Offspring resulting from heterozygous Hop
intercrosses were genotyped as indicated. Mendelian ratios were found prior to E10.5, but only approximately half the expected numbers of
homozygotes were identified at E12.5 and thereafter.
conditions in which other homeodomain proteins exhibit was detected in the same pattern as that of endogenous
Hop mRNA transcripts (Figures 5A and 5B). At E9.5,sequence specific DNA binding properties.
-galactosidase activity was evident in the branchial
arches and in the myocardium (Figure 5A). Activity per-Inactivation of Hop in Embryonic Stem Cells
sisted strongly in all four chambers of the heart (FigureWe constructed a targeting vector designed to replace
5B) and was detected in the neural tube and lung atthe entire Hop coding sequence with lacZ (Figure 4A).
later stages (not shown).We identified 4 correctly targeted R1 ES cell clones out
of 150 G418/gancyclovir-resistant colonies. Germline
transmission was achieved from 2 independent clones Partial Embryonic Lethality and Heart Failure
in Hop Null Embryosand confirmed by Southern blot analysis (Figure 4B).
Heterozygous Hop-deficient mice are viable and fer- We genotyped 182 three-week-old pups resulting from
crosses between heterozygous Hop mice on a mixedtile. We intercrossed heterozygous mice to obtain homo-
zygous offspring. Northern blot analysis of total RNA 129/Sv x C57BL/6 genetic background (Figure 4E). We
identified approximately half the number of expectedextracted from newborn wild-type, heterozygous, and
homozygous hearts using the entire Hop cDNA as probe homozygous Hop-deficient pups. Similar results were
obtained using mice derived from a second indepen-confirmed the absence of Hop mRNA transcripts in ho-
mozygous-deficient mice (Figure 4C). A polyclonal rab- dently targeted ES cell line. We examined litters at vari-
ous stages of gestation and just after birth to determinebit antibody raised against bacterially expressed Hop
detected endogenous Hop protein in heart extracts of the timing of partial demise of homozygous Hop-defi-
cient mice. At E9.5/10.5 we found the expected numberwild-type embryos (Figure 4D). In contrast, no immuno-
reactivity was detected in extracts from Hop/ embryos of homozygotes, while at E12.5 significant loss had oc-
curred indicating that Hop deficiency results in partial(Figure 4D). Thus, our targeting strategy that removed
the entire coding region of Hop results in a null allele. embryonic demise between E10.5 and E12.5.
At E9.5 and earlier, we could not detect phenotypicOur targeting approach results in the insertion of the
bacterial lacZ gene and replacement of the Hop gene. abnormalities in Hop deficient embryos. However, by
E10.5, significant developmental defects were apparent.In heterozygous Hop embryos, -galactosidase activity
Cell
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Figure 5. Targeted Replacement of Hop with
lacZ Results in Embryonic Heart Failure
(A) Heterozygous E9.5 Hop embryo reveals
-galactosidase activity in the branchial
arches and heart.
(B) -galactosidase activity is detected in all
four cardiac chambers at E11.5.
(C) Wild-type E11.5 embryo resulting from a
heterozygous Hop intercross.
(D) Homozygous Hop deficient (Neo-removed)
littermate of the embryo shown in (C) with a
hemorrhagic pericardial effusion (arrow).
(E) Sagittal section of a heterozygous E11.5
embryo revealing -galactosidase activity in
the ventricle and normal anatomy.
(F) Sagittal section of homozygous littermate
reveals a pericardial effusion (ef).
(G) Higher power of myocardium shown in (E).
(H) Higher power of myocardium shown in (F).
Note the thinned compact zone (arrows, H)
when compared to the heterozygote (ar-
rows, G).
(I) Whole-mount in situ analysis reveals ex-
pression of zebrafish Hop RNA in the heart
(ht, arrow) of this cleared embryo 48 hr post
fertilization (hpf; ys, yolk sac). Morpholino-
modified antisense oligonucleotides against Hop result in impaired cardiac development and function in zebrafish.
(J) Control zebrafish embryo (48 hpf) injected with a control -Hop morpholino antisense oligonucleotide containing a 4 basepair alteration
has a normal phenotype. White arrow indicates pericardium.
(K) Zebrafish embryo at 48 hpf after injection with -Hop morpholino with large pericardial effusion (arrows). Video images documenting slow
heart rate and significantly impaired circulation are available upon request.
About half of the Hop-deficient embryos examined at tions (Figures 5J and 5K). The heart rate was less than
half of that of controls and effective circulation wasE10.5 had gross pericardial effusions, often containing
sero-sanguinous exudates. This phenotype was ob- dramatically impaired (Video images available upon re-
quest). This phenotype is remarkably similar to that ofserved both before (not shown) and after germline re-
moval of the floxed pGKneo cassette (Figures 5C and affected Hop-deficient mouse embryos and indicates
that Hop deficiency is associated with impaired cardiac5D). Histologic analysis confirmed the presence of peri-
cardial effusions, often with associated red blood cells contractile function and ineffective circulation.
suggesting microperforation of the cardiac wall (Figures
5E and 5F). Indeed, we occasionally noted small perfora- Hop Modulates the Transcriptional Activation
tions of the myocardium. The myocardial wall was of Cardiac Promoters
thinned with a poorly developed compact zone (Figures Since Hop was unable to bind DNA independently, we
5G and 5H). Hop-deficient embryos without pericardial tested the ability of Hop to modulate the transcriptional
effusions had histogically normal appearing hearts. activity and DNA binding characteristics of other car-
These results suggest an incompletely penetrant embry- diac-specific factors. Nkx2-5, Gata4, and SRF are able
onic lethal phenotype on a mixed 129/Sv x C57BL/6 to synergistically activate cardiac-specific gene expres-
background resulting from embryonic heart failure. sion by binding to conserved elements in cardiac pro-
moter/enhancer sequences.
We assayed the effects of cotransfecting Hop in NIH/Inhibition of Hop Expression Results in Defective
Cardiac Function in Zebrafish 3T3 cells with cardiac-specific promoter-driven reporter
plasmids and expression vectors for Nkx2-5, Gata4, andIn order to examine the role of Hop in an animal model
in which we could monitor embryonic cardiac function, SRF. When the -cardiac actin (-CA) promoter was
used to direct luciferase expression, cotransfection ofwe perturbed Hop expression in zebrafish embryos us-
ing antisense morpholino-modified oligonucleotides Nkx2-5, Gata4, and SRF induced 15-fold activation. Co-
transfection of Hop results in a dose-dependent reduc-(Nasevicius and Ekker, 2000). Zebrafish Hop is ex-
pressed in the myocardium, as demonstrated by whole- tion in luciferase activity compared with control vector
(Figure 6A). A similar inhibitory effect is observed whenmount in situ hybridization (Figure 5I). Injection of 6 to
9 ng of either of two distinct anti-Hop antisense morpho- the atrial natriuretic factor (ANF) promoter was used to
direct expression of a human growth hormone reporterlino oligonucleotides into fertilized oocytes resulted in
one and two day embryos with dramatic impairment of gene (Figure 6B). Both the -CA promoter and the ANF
promoter contain SRF binding sites and mediate syner-cardiac function when compared to control, uninjected
embryos or to embryos injected with mutated morpho- gistic activation by SRF, Nkx2-5, and Gata4. However,
Hop did not inhibit all cardiac-specific promoter reporterlinos containing four nucleotide alterations. At 48 hr post
fertilization (hpf), injected embryos were smaller than constructs. The 124cTnC promoter does not contain
SRF binding sites but is known to be activated by Gata4.controls and 75% had large pericardial fluid collec-
Hop Is an Unusual Homeobox Gene
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Figure 6. Hop Inhibits SRF-Dependent Car-
diac Gene Transcription
(A) COS7 cells were transfected with an -CA
luciferase reporter plasmid (CA-luc), ex-
pression plasmids for Nkx2-5, Gata4, and
SRF, and with increasing amounts of Hop ex-
pression plasmid (pcDNA3-Hop). Maximal
activation (15-fold) with Nkx2-5, Gata4, and
SRF was designated 100%. Hop cotransfec-
tion resulted in dose-dependent inhibition of
transcription. Results shown in panels (A–C),
(F), and (K) were normalized for transfection
efficiency and represent the average of three
independent experiments performed in tripli-
cate, with error bars representing the stan-
dard deviation.
(B) Hop also inhibited activation of an atrial
natriuretic factor human growth hormone re-
porter plasmid (ANF-hGH).
(C) Hop did not inhibit GATA4 activation of a
cardiac troponin C luciferase reporter plas-
mid (124cTnC-luc) that does not contain
SRF binding sites.
(D) Northern blot analysis of endogenous ANF
expression in hearts from wild-type (/) and
Hop knockout (/) newborn mice. ANF is
upregulated in mutant hearts. Ethidium bro-
mide staining of the RNA gel is shown below
to indicate equal loading of RNA.
(E) RT-PCR analysis of heart RNA from E10.5
wild-type (/) and Hop knockout (/) em-
bryos. ANF, myoglobin, MLC2v, and -CA ex-
pression are increased in the mutant hearts.
GAPDH expression was used to demonstrate
equal amounts of RNA.
(F) Hop transfection of COS7 cells results in
dose-dependent inhibition of myocardin in-
duced activation of an SM22-luciferase re-
porter construct.
(G) EMSA reveals binding of epitope tagged
SRF to radioactively labeled SRE (lanes 1,3).
Antibodies specific for epitope tagged SRF
(SRF Ab) result in a supershift of the SRF/
SRE complex (lane 2). Hop itself is unable to
bind to SRE (lane 4). Addition of in vitro
transcribed and translated Hop with SRF results in inhibition of DNA binding by SRF (lane 5). Hop does not inhibit binding of GATA4 and
Nkx2.5 to their respective binding sites (lanes 6–9). (Lanes 1 and 2, 3–5, 6–9 are from different gels).
(H) GST-Hop interacts with in vitro translated and transcribed SRF. GST or GST-Hop bound to agarose beads was mixed with radioactive
SRF and bound SRF was visualized by autoradiography. SRF bound to GST-Hop (lane 2) but not to GST alone (lane 1). The SRF input material
is shown below.
(I) SRF and Hop interact in cultured cells. Immunoprecipitation of myc epitope-tagged Hop followed by Western blot for HA epitope-tagged
SRF (IP Western) was performed using nuclear extracts from untransfected COS7 cells (lane 1) or cells transfected with Hop (lane 2), SRF
(lane 3) or SRF plus Hop (lane 4). SRF was detected by Western blot after immunoprecipitation of Hop only if Hop and SRF were both present
(arrowheads, lane 4).
(J) A mutation of 4 amino acids in the second helix of Hop (H2) reduces its ability to bind radiolabeled epitope tagged-SRF containing a
carboxy-terminal truncation (amino acids 1–296; lane 3). Wild-type Hop and a mutant containing five altered amino acids in the third helix
(H3) are able to bind to this form of SRF (lanes 2 and 4).
(K) Transfection of H2 Hop does not repress myocardin activation of CA-luc in COS7 cells. However H3 Hop represses similar to wild-type
Hop.
(L) (top) EMSA demonstrating that wild-type Hop (WT) and H3 Hop repress binding of SRF to its binding site (SRE), while H2 Hop does not
repress. (bottom) Wild-type and mutant Hop (H2 and H3) in vitro translated proteins express at equal levels and were used in 6J and 6L.
Cotransfection of Hop with a124cTnC-luciferase plas- for myoglobin, myosin light chain 2v (MLC2v), and -CA
were all upregulated in Hop/ embryonic hearts (Figuremid had no effect (Figure 6C). Likewise, Hop did not
affect the activity of an SV40 promoter-reporter con- 6E), consistent with a role for Hop in the negative modu-
lation of SRF-dependent cardiac-specific gene expression.struct (not shown).
If Hop functions to modify cardiac-specific gene tran-
scription in vivo, we would expect alterations in the Hop Inhibits the Ability of Myocardin to Activate
SRF-Dependent Transcriptionexpression of downstream genes in Hop null mice. ANF
message was upregulated in Hop/ hearts compared Recently, a potent transcriptional cofactor for SRF
named myocardin has been described (Wang et al.,to wild-type littermates (Figure 6D). Likewise, transcripts
Cell
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2001). A dominant-negative form of myocardin is able 4, Figure 6J). The H2 mutant was unable to inhibit myo-
cardin activation of SRF-dependent transcription (Fig-to impair cardiac development in Xenopus embryos. We
sought to determine if Hop could modulate the ability ure 6K) and did not inhibit SRF binding to DNA (Figure
6L). The H3 mutant (and other mutants not shown) inhib-of myocardin to activate SRF-dependent transcription.
As has been previously described, we found that myo- ited SRF-dependent transcription and DNA binding (Fig-
ures 6K and 6L). Both wild-type and mutant proteinscardin was able to induce dramatic (500–1600-fold) acti-
vation of ANF or SM22 reporter constructs. Hop was were expressed at equal levels in these experiments.
These results suggest that Hop interacts with SRF viaable to significantly inhibit this activation in a dose-
dependent fashion (Figure 6F and data not shown). the second  helix, and strongly support the conclusion
that Hop inhibits SRF-dependent transcription by physi-
cally interacting with SRF and affecting SRF interactionHop Interacts with SRF and Modulates SRF
with DNA.Interactions with DNA
The ability of Hop to inhibit SRF-dependent gene activa-
tion by either myocardin or by Nkx2-5, Gata4, and SRF Discussion
suggested that Hop might affect the ability of SRF to
interact with DNA or with other cofactors. We tested the In this report, we have described the identification and
functional analysis of a gene that is closely related toability of Hop to affect SRF binding to preferred serum
response element (SRE) binding sites derived from the known homeobox genes, yet encodes a protein that
fails to bind DNA and contains no other recognizableSM22 or c-fos enhancers by performing EMSA using
in vitro transcribed and translated SRF and Hop. The structural motifs. Hop encodes the smallest known ho-
meodomain protein. While all known homeodomain fac-predominant complex formed upon addition of SRF to
radiolabeled c-fos SRE contained SRF protein, since tors are thought to function, at least in part, by binding
to DNA, Hop acts to modulate SRF-dependent transcrip-addition of antibodies directed against the epitope tag
of SRF resulted in a delayed migration (supershift) of tion and cardiac-specific gene expression in the ab-
sence of intrinsic DNA binding capability. Our resultsthat complex (lane 2, Figure 6G). Hop alone was unable
to bind to radiolabeled SRE (lane 4, Figure 6G) and did suggest a model by which Hop modulates SRF-depen-
dent cardiac gene transcription by binding directly tonot result in altered electrophoretic migration of SRF
bound to SRE. Rather, Hop inhibited the ability of SRF SRF and reducing the ability of SRF to bind to DNA.
Hop expression is first observed at early stages ofto interact with the SRE (lane 5, Figure 6G). We obtained
similar results using the SM22 SRE and nuclear ex- cardiogenesis just after that of Nkx2-5, and it remains
strongly expressed in the heart throughout developmenttracts of COS7 cells expressing SRF and Hop (not
shown). The addition of reticulocyte lysate alone, or of and adulthood. Our data indicate that Nkx2-5 directly
activates Hop expression, since Hop is downregulatedunrelated proteins expressed in vitro, had no effect on
SRF binding to SRE. Hop did not bind to Nkx2-5 and in Nkx2-5 null embryos, and since Nkx2-5 can activate a
functional Hop promoter/enhancer construct in culturedGata4 binding sequences and did not affect the ability
of Nkx2-5 or Gata4 to interact with their cognate binding cells by binding directly to Nkx2-5 binding sites. Hop
acts in a negative feedback loop to inhibit the ability ofsites (lanes 6–9, Figure 6G). Hence, Hop specifically
impairs the ability of SRF to bind to DNA. Nkx2-5 to activate a subset of target genes, namely
those that are dependent upon SRF activity (Figure 7).We performed GST pull-down experiments and coim-
munoprecipitation assays to determine if Hop interacts This model suggests a delicate balance of transcrip-
tional regulation that profoundly impacts on cardiacdirectly with SRF. GST alone was unable to interact
directly with radiolabeled SRF prepared in vitro (lane 1, function. In the absence of Hop in mice, cardiac develop-
ment is disrupted such that about half of the null em-Figure 6H), while GST-Hop could bind to SRF (lane 2,
Figure 6H). Next, COS7 cells were transfected with epi- bryos develop embryonic heart failure and die between
E10.5 and E12.5. This is precisely the period of gestationtope-tagged Hop and SRF or with control vectors. Im-
munoprecipitation with an antibody directed against the at which numerous cardiac mutant embryos succumb
to deficiencies involving a thin-walled myocardium (Au-Hop epitope tag followed by Western blotting to detect
SRF confirmed the ability of Hop to interact with SRF erbach, 1954; Lyons et al., 1995; Srivastava et al., 1997),
supporting the conclusion that heart failure accountsin vivo (Figure 6I). Hence, Hop forms a stable complex
with SRF that correlates with the ability of Hop to impair for lethality in Hop mutant mouse embryos. Inhibition
of Hop protein expression in zebrafish also results inSRF binding to DNA and SRF-dependent gene tran-
scription. specific cardiovascular functional defects, and the im-
pairment of effective circulation in this model confirmsWe carried out both targeted and random mutagene-
sis of the Hop cDNA and examined the ability of several a role for Hop in supporting contractile function.
Interestingly, some null murine embryos survive tosubtly mutated Hop proteins to interact with SRF. Alter-
ation of 4 amino acids in the predicted second  helix birth and appear healthy and fertile up to 6 months of
age. Invasive hemodynamic analysis has failed to revealof Hop (a mutant called H2 in which amino acids 35–39
LIAAE were changed to AAASM) dramatically reduced significant alterations in myocardial function in these
adult animals (data not shown). Genetic modifiers mayinteraction with SRF (lane 3, Figure 6J).
Other mutations examined, including a construct en- alter the degree of phenotypic penetrance when Hop-
deficient mice are bred on distinct genetic backgrounds,coding a similar mutation in the third predicted  helix
(H3, in which amino acids 49–53 KWFKQ were changed as has been amply demonstrated in the case of other
mouse mutations (Nadeau, 2001; Wittman and Ham-to AAASM), retained the ability to interact with SRF (lane
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mutations in the human homolog of Hop will be identified
in association with related cardiac conditions.
Experimental Procedures
Cloning of Hop
Hop was identified from the EST database at the National Center
for Biotechnology Information using the Pax3 homeodomain se-
quence as query. A genomic clone for Hop was obtained by using
the Hop cDNA to screen a mouse  genomic library (Stratagene, La
Jolla, CA; 129/Sv FIX II library).
In Situ Hybridization
Whole-mount and radioactive in situ hybridization was performed
as described (Schulte-Merker et al., 1992; Wawersik and Epstein,
2000) and our protocols are available at www.med.upenn.edu/mcrc.
RNA Analysis
One g each of poly (A) RNA from mouse tissues was used for
Northern blots. RT-PCR was performed using heart tissue from
E10.5 embryos. RNA was prepared using Trizol (Life Technologies,
Rockville, MD). Qualitative comparison of gene expression was de-
termined after 25 cycles.
Glutathione S-Transferase (GST) Fusion Protein, In Vitro
Translated Protein, and Anti-Hop Antibody ProductionFigure 7. Model for Hop Modulation of Cardiac Transcription
Proteins for EMSA and coimmunoprecipitation experiments wereNkx2-5 activates expression of Hop, which feeds back to inhibit the
made using the TNT coupled transcription/translation system (Pro-ability of Nkx2-5 to activate SRF-dependent cardiac-specific genes
mega, Madison, WI). GST-Hop fusion protein was prepared by stan-such as ANF and  CA, while gene activation that is not dependent
dard techniques and used to immunize rabbits (Cocalico Biologicals,on SRF (“Other”) is unaffected.
Inc., Reamstown, PA).
burgh, 1968). We have not identified other related Hop- Immunoprecipitations/Western Analysis
COS7 cells were transfected with pcDNA3 myc-Hop and/orlike genes in the mouse or human genomes, although we
pCGN-SRF (HA tagged) using Effectene (Qiagen, Valencia, CA). Cellcannot rule out the possibility of functional redundancy
extracts were isolated 48 hr after transfection, and 500 g waswith known or unknown gene products that could ac-
immunoprecipitated using a mouse -myc monoclonal antibodycount for the partial penetrance of the lethal phenotype.
(-myc1-9E10) and protein A/G sepharose. Cell extracts were pre-
It is possible that Hop deficiency causes a delay in myo- pared by sonication in GS buffer (40% glycerol, 40 mM HEPES,
cardial maturation, which leads to the stochastic occur- 100 mM KCl, and 2 mM -mercaptoethanol). Western blotting with
Western Breeze (Invitrogen Co., Carlsbad, CA), mouse monoclonalrence of myocardial rupture as hemodynamic forces
-HA antibody (Roche, Indianapolis, IN), and rabbit polyclonal -SRFincrease during midgestation. If rupture and ensuing
(Santa Cruz Biotechnology) were used.demise do not occur, subsequent myocardial matura-
tion and adaptive capacity may suffice to allow for nor-
Transfectionsmal or near normal development. This type of stochastic
NIH-3T3 fibroblast cells were transfected using Effectene (Qiagen)
event could explain the partially penetrant embryonic as directed. Reporter constructs included -CA-Luc (Chen et al.,
lethal phenotype that we observe. 1996), rat B-type natriuretic peptide promoter cloned into p0GH
(Nichols Institute, San Juan Capistrano, CA) (ANF-hGH), SM22-LucThe ability of Hop to repress transcriptional activity
and 124cTnC-Luc (kindly provided by M. Parmacek), and con-induced by Nkx2-5 and myocardin implicates a common
structs containing either 5 kb or 261 bp of the Hop promoter clonedmechanism of action involving SRF. Myocardin func-
into p0GH. Mutagenesis utilized QuikChange Site-Directed Muta-tions by binding to SRF (Wang et al., 2001), as does
genesis and GeneMorph Kits (Stratagene). Myocardin was cloned
Nkx2-5 (Sepulveda et al., 1998). Myocardin contains a by PCR from a mouse E15 cDNA library (Clontech, Palo Alto, CA)
SAP domain that bears homology to the first helices and is identical to the myocardin A sequence (accession number:
AF437877). pSV-galactosidase (Promega) was used to normalizeof a homeodomain, suggesting an ancestral structural
for transfection efficiencies and pcDNA3 was used to equalize thehomology between myocardin, Nkx2-5, and Hop.
amount of DNA in each transfection.The small size of Hop and its ability to inhibit the
activity of Nkx2-5 is reminiscent of the action of Id and
EMSA, DNA Binding Site Selection Assayits ability to inhibit the function of other helix-loop-helix
Binding site selection conditions have been described previously
(HLH) proteins. Id genes encode HLH proteins that lack (Epstein et al., 1994). EMSA experiments utilized 	-32P ATP-labeled
the adjacent basic domain required for DNA binding in oligonucleotides (50,000 cpm), 0–7 l of in vitro translated proteins,
300 ng of poly(dI-dC) in 0.5 
 TBE, incubated for 30 min at roombHLH proteins such as MyoD. Id functions to inhibit
temperature in a final volume of 20 l. The reaction mixture wasDNA binding by other bHLH proteins and hence plays
loaded on a 5% polyacrylamide gel in 0.5 
 TBE. Oligonucleotideimportant roles in development and differentiation (Ben-
sequences are available upon request.ezra et al., 1990; Kreider et al., 1992).
Mutations in NKX2-5 have been associated with pedi-
Transgenic Mice Analysis
atric and adult structural heart disease and conduction A 5kb mouse Hop promoter fragment fused to a lacZ reporter gene
defects (Benson et al., 1999; Schott et al., 1998). Given was purified using Qiaex II (Qiagen) and an Elutip column (Schleicher
and Schuell, Keene, NH). DNA was injected into B6SJL/F1 eggs.the functional relationship of Hop with Nkx2-5, perhaps
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Gene Targeting Duboule, D. (1994). Guidebook to the Homeobox Genes (Oxford:
Oxford University Press).The targeting vector was based on the pPNT vector with the neomy-
cin resistance gene cassette that has been modified to contain Durocher, D., Charron, F., Warren, R., Schwartz, R.J., and Nemer,
flanked lox P sites (Tybulewicz et al., 1991). The 5 arm of the tar- M. (1997). The cardiac transcription factors Nkx2–5 and GATA-4 are
geting construct consists of a 5 kb NotI -NarI fragment that is 5 of mutual cofactors. EMBO J. 16, 5687–5696.
the Hop coding region fused to a LacZ reporter gene, and the 3
Epstein, J., Cai, J., Glaser, T., Jepeal, L., and Maas, R. (1994). Identifi-arm consists of a 2 kb KpnI-EcoRI fragment that flanks the Hop 3
cation of a Pax paired domain recognition sequence and evidenceuntranslated region. The NotI, KpnI, and EcoRI restriction sites were
for DNA-dependent conformational changes. J. Biol. Chem. 269,engineered. The targeting vector was linearized with NotI and elec-
8355–8361.troporated into R1 ES cells (kindly provided by Andras Nagy, To-
Fu, Y., Yan, W., Mohun, T.J., and Evans, S.M. (1998). Vertebrateronto, Canada). Genotyping was performed by Southern analysis of
tinman homologues XNkx2–3 and XNkx2–5 are required for heartKpnI digested genomic DNA. Mice were maintained on a mixed 129/
formation in a functionally redundant manner. Development 125,Sv X C57Bl/6 genetic background. CMV-Cre recombinase trans-
4439–4449.genic mice used to remove the floxed neomycin resistance gene
cassette kindly provided by P.A. Labosky. Harvey, R.P. (1996). NK-2 homeobox genes and heart development.
Dev. Biol. 178, 203–216.
Genotyping Hop Mutants Jones, D.T., Taylor, W.R., and Thornton, J.M. (1992). A new approach
Hop mutant mice were genotyped by Southern blotting and by PCR to protein fold recognition. Nature 358, 86–89.
(primer sequences available upon request).
Kissinger, C.R., Liu, B.S., Martin-Blanco, E., Kornberg, T.B., and
Pabo, C.O. (1990). Crystal structure of an engrailed homeodomain-
Morpholino Inhibition in Zebrafish DNA complex at 2.8 A resolution: a framework for understanding
To deplete Hop in zebrafish, 6 and 9 ng of morpholino antisense homeodomain-DNA interactions. Cell 63, 579–590.
oligonucleotide (Gene Tools, LLC, Philomath, OR) directed against
Komuro, I., and Izumo, S. (1993). Csx: a murine homeobox-con-the zHop 5 untranslated region (zHop as1, 5-TAAACTCCGAACAG
taining gene specifically expressed in the developing heart. Proc.CAAACGAGCAG-3) was injected into the yolk region at the one-
Natl. Acad. Sci. USA 90, 8145–8149.cell stage. 7.5 ng of a second morpholino antisense oligonucleotide
Kreider, B.L., Benezra, R., Rovera, G., and Kadesch, T. (1992). Inhibi-directed against the zHop amino-terminal coding region (zHop as2,
tion of myeloid differentiation by the helix-loop-helix protein Id. Sci-5-ACGCCGCGTTTCCATTCGCGCTCAT-3), and a negative control
ence 255, 1700–1702.for zHopas1 containing 4 mutations (zHopas1mut, 5-TGAACTGC
GAACAGCAGACAAGCAG-3) were also injected. Lyons, I., Parsons, L.M., Hartley, L., Li, R., Andrews, J.E., Robb, L.,
and Harvey, R.P. (1995). Myogenic and morphogenetic defects in
the heart tubes of murine embryos lacking the homeo box geneAcknowledgments
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Accession Numbers
The myocardin A sequence reported in the paper is identical to
GenBank accession number AF437877. The GenBank accession
number for the murine and zebrafish Hop sequences reported in
this paper are AF536202 and AF536198, respectively.
